Himachal seeking to boost healthcare through facilities for robotic surgery
Shimla:
Himachal Pradesh
is witnessing a transformation in the health sector, as Chief Minister Sukhvinder Singh Sukhu's vision of providing world-class medical facilities to the people is now becoming a reality, an official release said.
The Atal Institute of Medical Super Specialities at Chamiyana in Shimla is set to become the first
medical institute
in the state where surgeries will be performed using the latest robotic technology. A state-of-the-art
surgical robot
, procured at Rs 28 crore on the lines of AIIMS Delhi, has already arrived at Chamiyana, and the installation process will be completed by July, after which surgeries using this
advanced technology
will begin.
Principal of the Atal Institute of Medical Super Specialities at Chamiyana, Dr Brij Lal, today here said that
robotic surgery
would benefit both patients and doctors. He explained that only a very small incision is required in robotic procedures, which means less blood loss and minimal need for transfusions. The patients experience less pain, recover faster and can be discharged from the hospital sooner.
The surgeons, too, will benefit from this technology as robotic systems would provide them better precision and control. They do not feel fatigued even during long surgeries, which allows them to perform more procedures in less time. The system also offers a clear and magnified 3D view inside narrow and complex areas of the body and reduces the chances of any errors, the release said.
Following the directions of the Chief Minister, the robotic surgery equipment will soon be delivered to Dr Rajendra Prasad Government Medical College, Tanda as well.
Thereafter, the machines will be installed in IGMC Shimla, Medical College Hamirpur and other government medical colleges in a phased manner. This will benefit thousands of patients across the state and reduce the need to travel outside Himachal for expensive surgeries, the release said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
2 hours ago
- Indian Express
Whoop, Garmin, Fitbit: Best premium fitness trackers in 2025
Fitness trackers are getting smarter, sleeker and more feature-packed than ever. From real-time heart rate and SpO2 tracking to advanced sleep analysis, today's wearables are built for much more than counting steps. Whether you're a gym regular or just trying to build better habits, here's a look at some of the best premium fitness trackers available in India right now. Fitbit's Charge 6 blends smart features with serious fitness tracking. It offers ECG, a form of advanced heart tracking, built-in GPS, blood oxygen saturation (SpO2) tracking, and workout detection across more than 40 exercise types. The bright AMOLED screen displays Google Maps, Wallet, and even YouTube Music controls. Fitbit's Active Zone Minutes help optimise workout intensity, while the 7-day battery life ensures minimal downtime. The Charge 6 also syncs with gym equipment (if able to) and includes six months of Fitbit Premium, giving access to deeper insights and personalised recommendations. You can buy it for as low as Rs 14,799. For data-focused users, the Garmin Vivosmart 5 offers a reliable and no-fuss fitness companion. It features a monochrome OLED touchscreen and tracks heart rate, SpO2, stress levels, sleep stages, and even energy levels through Garmin's 'Body Battery' metric. While there is no built-in GPS, it lets you track your location when using the phone GPS. Safety features include emergency alerts and LiveTrack. With up to 7 days of battery life, this slim and lightweight tracker has a water resistance level of up to 50 m deep, making it ideal for both workouts and showers. It is currently selling for Rs 12,990. The FitVII Ole is a feature-rich tracker equipped with a 1.78-inch AMOLED display, 24/7 heart rate, SpO2, blood pressure tracking, and sleep analysis. It supports over 100 sport modes and comes with IP68 water and dust resistance. You also get smart notifications, weather updates, and breathing training. The Ole stands out with its Apple Watch-inspired design and customisable watch faces. The device claims up to 7 days of battery life with regular use, making it one of the best-looking smart trackers under Rs 11,000. It is available on Amazon for Rs 10,878. Favoured by elite athletes like Virat Kohli and LeBron James, the Whoop 4.0 doesn't have a display and focuses entirely on performance recovery, strain, and sleep metrics. The tracker pairs with a powerful app that offers detailed health analytics, daily recovery stores, and coaching insights. It features 24/7 monitoring of heart rate variability (HRV), skin temperature, and blood oxygen, and is waterproof up to 10 metres. The sensor fits into various accessories like arm sleeves or compression wear, and the minimalist design sets it apart from traditional wearables. However, a subscription is required to use the device. You can buy it for Rs 30,000 with a complimentary 12-month membership. For users who want a slim and simple fitness band, the Fitbit Inspire 3 offers great value. It includes heart rate tracking, SpO2, skin temperature variation, stress management, and sleep stage analysis. The bright AMOLED screen displays call, text, and app notifications. While it lacks built-in GPS, it supports connected GPS and offers up to 10 days of battery life. Lightweight and swimproof, the Inspire 3 also supports mindfulness sessions and guided breathing, making it a great entry-level premium tracker for everyday wellness. It is currently available for Rs 8,899. (This article has been curated by Arfan Jeelany, who is an intern with The Indian Express)
Indian Express
2 hours ago
- Indian Express
Admissions to 20 PG courses in IP University through CUET scores
The Guru Gobind Singh Indraprastha University (GGSIPU) Delhi will offer admissions to 20 postgraduate programmes through the Common University Entrance Test Postgraduate (CUET PG) scores for the academic session 2025-26. The 20 postgrauduate programmes include MBA, MCA (software engineering) or MCA, MAMC, MPT (M/N/S/C), MSc (environment management), LLM, MA (English), MEd, MTech (CSG), MTech (EG), MA (economics), PG in applied geoinformatics, MSc (yoga), MSc (medicinal chemistry and drug design), MSc (bioinformatics), MSc (molecular diagnostics), MSc (microbiology), MS (packaging technology), BEd and BEd (special education). Candidates interested in admissions to these programmes through CUET scores can apply online by July 15 with a fee of Rs 2,500 for application and counselling. Detailed information is available on the university's websites – and CUET PG scores will be used for admission to PG programmes after the merit list of national-level tests or GGSIPU Common Entrance Test (CET) and university-conducted entrance exams for affiliated programmes is exhausted. IPU, this year, has introduced an orphan children quota, in addition to the existing Single Girl Child quota introduced last year. The quota will be effective from the academic session 2025-26. Under this quota, one additional seat will be reserved in each university schools and programmes, and the selected students will be eligible for a 100 per cent fee waiver under the university's EWS scheme. The University has launched an admission chatbot service. The IP University admission chatbot service seeks to provide instant answers to queries related to admissions in various programmes for the new session. The link to the new service is available on the University's main website — Using this service, prospective applicants can get immediate answers to their queries related to admissions in various programmes for the new session, a statement issued by the university said. IPU, this year, is offering 46 master's degree programmes, 40 PhD programmes, and 34 undergraduate degree programmes for over 40,000 seats.
Indian Express
4 hours ago
- Indian Express
Delhi drugs control department cracks down on sale of fake cholesterol medicines
The Delhi drugs control department recently uncovered a multi-level distribution network involved in the sale and circulation of spurious Rosuvas F 20 tablets, a prescription drug used to manage cholesterol and triglyceride levels, officials said on Friday. The action followed a complaint from Sun Pharmaceutical Industries Ltd, which reported that fake versions of its Rosuvas F 20 tablets were being sold by a retail outlet in central Delhi. The complaint mentioned a multi-level supply chain involving multiple wholesalers and distributors across the city. Rosuvas F 20 is a fixed-dose combination drug containing Rosuvastatin (20 mg) and Fenofibrate (160 mg). It is commonly prescribed to patients who require medication to manage high cholesterol and triglyceride levels, especially when lifestyle changes alone are not sufficient. The drug plays a vital role in preventing serious cardiovascular conditions such as heart attacks and strokes. Drugs control department officials said Rosuvas F 20 tablets were a fast-moving drug, and on June 14 and 15, 1,800 spurious tablets worth Rs 88,000 were seized from two locations in Okhla and Bhagirath Palace. 'On June 14, we first received a complaint from Rajinder Nagar, but no stock was found. A link was established in Okhla and Bhagirath Palace, where raids were conducted,' an official said. Officials noted irregularities and a suspicious absence of genuine stock at several distribution points, which ultimately led them to a firm located in the Okhla Industrial Area. 'Visual inspection and comparison with authentic samples suggested that the seized products were spurious — their appearance and packaging did not match those of the legitimate manufacturer,' said an official. Here, additional suspect stock of Rosuvas F 20 was found. Legal samples were collected from Bhagirath Palace, Chandni Chowk—one of Delhi's busiest medicine markets—and sent to a government laboratory for quality testing, while manufacturer verification is also underway, officials revealed. The department has secured custody permission for the seized drugs through the Delhi High Court. 'We are now coordinating with authorities in other states to trace the full supply chain behind the fake medication,' the official said.
